Skip to main content

Advertisement

Springer Nature Link
Log in

A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease

  • Scientific Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Data availability

Not applicable.

References

  1. Horby P, Lim WS, Emberson JR, RECOVERY Collaborative Group et al (2021) Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 384:693–704

    Article  CAS  PubMed  Google Scholar 

  2. WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group (2020) Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324:1330–1341

    Article  Google Scholar 

  3. Carlet J, Payen D, Opal SM (2020) Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19. Lancet 396:e61–e62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Kwon KE, Jung SY, Baek MS, Kim WY (2022). Corticosteroids in H1N1, non-viral, and COVID-19 ARDS. Intensive Care Med 48:1809–1811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wagner C, Griesel M, Mikolajewska A et al (2022) Systemic corticosteroids for the treatment of COVID-19: equity-related analyses and update on evidence. Cochrane Database Syst Rev 11(11):CD014963. https://doi.org/10.1002/14651858.CD014963.pub2

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Additional members of the “Steroids for Covid Research Group”: Michael A Matthay, Cardiovascular Research Institute, University of California, San Francisco, California; Benoît Misset, Rouen University Hospital Charles Nicolle, Rouen, France; Guillaume Monneret, Hospices Civils de Lyon, Lyon, France; Greet Van den Berghe, Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Louvain, Belgium. We would like to thank Professor Jean Marc Cavaillon, Institut Pasteur, Paris, France, for his useful insights.

Author information

Authors and Affiliations

  1. Past president of the European Society of Intensive Care Medicine (ESICM), Past President of the World Alliance Against Antibiotic Resistance (WAAAR), past member of the International Sepsis Forum (ISF), Creteil, France

    Jean Carlet

  2. Paris Cité Sorbonne University; Department of Infectious Disease, Nice Alpes Cote d’Azur University, Nice, France

    Didier Payen

  3. University College London, London, UK

    Mervyn Singer

Authors
  1. Jean Carlet
    View author publications

    Search author on:PubMed Google Scholar

  2. Didier Payen
    View author publications

    Search author on:PubMed Google Scholar

  3. Mervyn Singer
    View author publications

    Search author on:PubMed Google Scholar

Consortia

the Steroids for Covid Study Group

  • Michael A Matthay
  • , Benoît Misset
  • , Guillaume Monneret
  •  & Greet Van den Berghe

Corresponding author

Correspondence to Jean Carlet.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carlet, J., Payen, D., Singer, M. et al. A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease. Intensive Care Med 51, 972–974 (2025). https://doi.org/10.1007/s00134-025-07878-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-025-07878-1